PDP1 and cancer: Consistent with the enrichment in glucose utilization in cancer cells with PDH depletion [36], CPI-613 treatment alone increased glucose uptake and lactate production in both HN6 and HN31 cells (Fig. 5A and B), suggesting that inhibition of mitochondrial metabolism by CPI-613 may elicit increasing compensatory glycolytic activity.